California Stem Cell Agency: "Valley of Death" Cash Will Get Treatments To Clinic
This article was originally published in The Pink Sheet Daily
Executive SummaryBut biotechs shouldn't expect salvation, as an anticipated loan program is off to a slow start.
You may also be interested in...
New endpoint guidelines – and matching grant funding from the California Institute for Regenerative Medicine – enhance possibility of demonstrating functional improvement in the Phase I/IIa trial of the stem-cell therapeutic.